Camlin Fine Sciences (CFS) has raised Rs 100 crore through the allotment of 10,000 senior, secured, redeemable, unlisted, unrated, non-convertible debentures (NCDs) of face value of Rs 100,000 on a private placement basis. The Securities Issue and Allotment Committee (the Committee) of the company in its meeting held on December 5, 2024 has inter alia, approved the allotment of the same.
Camlin Fine Sciences (CFS) is the leading integrated manufacturer of the most preferred traditional antioxidants (Shelf Life Solutions) available.
